Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Papillomavirus Infections 1HIV Infections 1Cervical Cancer Screening 1Breast Neoplasms 1

Interventions

pembrolizumab 602Cyclophosphamide 545Magnetic Resonance Spectroscopy 524Radiotherapy 513Specimen Handling 506Nivolumab 412Cisplatin 380Carboplatin 368Biopsy 306Blood Specimen Collection 302Radiosurgery 290Paclitaxel 280Surveys and Questionnaires 270Gemcitabine 270Standard of Care 267Drug Therapy 263Dexamethasone 263fludarabine 262Bevacizumab 253venetoclax 251Oxaliplatin 209Capecitabine 201Rituximab 198Radiation 192Fluorouracil 189Ipilimumab 188durvalumab 184Doxorubicin 179Etoposide 176atezolizumab 175

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Coal Tar × 1 year × Clear all
NCT07538050 2026-05-28

SCALE AIM 2

The Cleveland Clinic

Phase NA Recruiting
1,000 enrolled
Gynecologic

Cervical Cancer Screening

NCT05012813 2026-03-09

Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer

OHSU Knight Cancer Institute

Phase NA Completed
28 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07225530 2026-02-25

(iSTAR)

Columbia University

Phase NA Recruiting
600 enrolled
Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡